Julie Jones

Julie Jones is the Founder and CEO of BioValeo Ltd, a contract research organization (CRO) focused on personalized medicines and immunology-based clinical trial services. Julie is passionate about the clinical research sector and the provision of safe and effective new treatments for patients.

Julie has been in the clinical research sector for over 20 years and has gained broad and diverse experience across the industry. Julie's most notable accomplishments include establishing a GMP facility for personalized oncology therapies, international clinical trial project management and trial portfolio management for pharmaceutical multinationals. In addition, she has created and implemented quality management systems, and led national governance and strategic development activities. She is recognized for industry consultation and development of numerous national templates and guidelines, and Ministerial ethics appointment.